Archive - March 2018
EU ready to review Shire’s lanadelumab for HAE
EMA to review Sanofi’s type I diabetes therapy
Takeda-Shire blockbuster deal: is it worth it?
Takeda eyes up Shire
2018 Career & Salary Survey Results: Pharma Gains Momentum
2018 Career & Salary Survey Results: Pharma Gains Momentum
FDA Expands Approval of Blincyto (blinatumomab) to Treat Minimal Residual Disease-Positive B-Cell Precursor Acute Lymphoblastic Leukemia
6 Reasons Why Summer Can Be Good For Your Health